Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2018-06-25 Tx date 2018-06-20 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-28,154.25
-13,095 vol $2.15 each |
30,000 | |
Filed 2018-02-28 Tx date 2018-02-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-90,938 vol |
||
Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-28 Tx date 2018-02-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-90,938 vol |
||
Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
90,938 | ||
Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
272,813 | ||
Filed 2018-02-28 Tx date 2018-02-27 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Ltd. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-90,938 vol |
0 | |
Filed 2018-02-28 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
43,095 | |
Filed 2017-04-13 Tx date 2016-05-26 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-13,095 vol |
17,460 | |
Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
272,813 | ||
Filed 2017-04-13 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Holder: 2089636 Ontario Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
90,938 | ||
Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
Filed 2016-06-20 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
41,190 | |
Filed 2016-06-17 Tx date 2016-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,309
+4,365 vol $2.82 each |
277,177 | |
Filed 2016-06-17 Tx date 2016-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,309.30
-4,365 vol $2.82 each |
26,190 | |
Filed 2016-02-10 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,555 | ||
Filed 2016-02-10 Tx date 2016-02-05 |
$TRX
Tribute Pharmaceuticals Canada Inc. (formerly Stellar Pharmaceuticals Inc.) |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-210,000 vol |
0 | |
Filed 2016-02-10 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Thrasher, Francis Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
272,812 |